Follow
Daniel Marks
Daniel Marks
Executive Medical Director, AstraZeneca; Consultant Physician, University College London Hospital; Honorary Associate Professor, University College London
Verified email at ucl.ac.uk
Title
Cited by
Cited by
Year
Defective acute inflammation in Crohn's disease: a clinical investigation
DJB Marks, MWN Harbord, R MacAllister, FZ Rahman, J Young, ...
The Lancet 367 (9511), 668-678, 2006
5162006
Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease
AM Smith, FZ Rahman, BH Hayee, SJ Graham, DJB Marks, GW Sewell, ...
Journal of Experimental Medicine 206 (9), 1883-1897, 2009
5132009
Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international …
I Roberts, H Shakur-Still, A Afolabi, A Akere, M Arribas, A Brenner, ...
The Lancet 395 (10241), 1927-1936, 2020
3032020
Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease
DJB Marks, K Miyagi, FZ Rahman, M Novelli, SL Bloom, AW Segal
Official journal of the American College of Gastroenterology| ACG 104 (1 …, 2009
2332009
Innate immunity in inflammatory bowel disease: a disease hypothesis
DJB Marks, AW Segal
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2008
1252008
Thoracic empyema: a 12-year study from a UK tertiary cardiothoracic referral centre
DJB Marks, MD Fisk, CY Koo, M Pavlou, L Peck, SF Lee, D Lawrence, ...
PloS one 7 (1), e30074, 2012
1212012
Crohn’s disease: an immune deficiency state
DJB Marks, FZ Rahman, GW Sewell, AW Segal
Clinical reviews in allergy & immunology 38, 20-31, 2010
1202010
The immunopathogenesis of Crohn's disease: a three-stage model
GW Sewell, DJB Marks, AW Segal
Current opinion in immunology 21 (5), 506-513, 2009
1132009
Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs
DJB Marks, K Dheda, R Dawson, G Ainslie, RF Miller
International journal of STD & AIDS 20 (5), 339-345, 2009
1062009
Outcomes from massive paracetamol overdose: a retrospective observational study
DJB Marks, PI Dargan, JRH Archer, CL Davies, AM Dines, DM Wood, ...
British journal of clinical pharmacology 83 (6), 1263-1272, 2017
822017
Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte‐colony stimulating factor
MWN Harbord, DJB Marks, A Forbes, SL Bloom, RM Day, AW Segal
Alimentary pharmacology & therapeutics 24 (4), 651-660, 2006
762006
Mycotic aneurysms: a case report, clinical review and novel imaging strategy
M Fisk, LF Peck, K Miyagi, MJ Steward, SF Lee, MB Macrae, ...
QJM: An International Journal of Medicine 105 (2), 181-188, 2012
732012
Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise
T Bharucha, A Rutherford, S Skeoch, A Alavi, M Brown, J Galloway, ...
Clinical radiology 72 (9), 764-771, 2017
662017
Phagocyte dysfunction and inflammatory bowel disease
FZ Rahman, DJB Marks, BH Hayee, AM Smith, SL Bloom, AW Segal
Inflammatory bowel diseases 14 (10), 1443-1452, 2008
612008
Defective innate immunity in inflammatory bowel disease: a Crohn's disease exclusivity?
DJB Marks
Current opinion in gastroenterology 27 (4), 328-334, 2011
552011
Novel translational model of resolving inflammation triggered by UV‐killed E. coli
MP Motwani, JD Flint, RPH De Maeyer, JN Fullerton, AM Smith, ...
The Journal of Pathology: Clinical Research 2 (3), 154-165, 2016
442016
Clinical features, microbiology and surgical outcomes of infective endocarditis: a 13-year study from a UK tertiary cardiothoracic referral centre
DJB Marks, C Hyams, CY Koo, M Pavlou, J Robbins, CS Koo, G Rodger, ...
QJM: An International Journal of Medicine 108 (3), 219-229, 2015
402015
Oxford handbook of gastroenterology and hepatology
S Bloom, G Webster, D Marks
Oxford University Press, USA, 2012
362012
Delayed resolution of acute inflammation in ulcerative colitis is associated with elevated cytokine release downstream of TLR4
FZ Rahman, AM Smith, BH Hayee, DJB Marks, SL Bloom, AW Segal
PLoS One 5 (3), e9891, 2010
352010
Lymphocyte activation gene (LAG)-3 is associated with mucosal inflammation and disease activity in ulcerative colitis
SM Slevin, LC Garner, C Lahiff, M Tan, LM Wang, H Ferry, B Greenaway, ...
Journal of Crohn's and Colitis 14 (10), 1446-1461, 2020
332020
The system can't perform the operation now. Try again later.
Articles 1–20